Department of Epidemiology and Biostatistics, School of Public Health, Anhui Hefei, China.
School of Stomatology, Anhui Medical University, Anhui Hefei, China.
Rheumatology (Oxford). 2021 Mar 2;60(3):1054-1066. doi: 10.1093/rheumatology/keaa835.
Recently, researchers have proposed a possible relationship between RA and the microbiome of the oral cavity and gut. However, this relation has not been systematically established. Herein, we conducted a comprehensive review of the pertinent literature to describe this possible association.
We systematically performed searches in databases, namely EMBASE, the Cochrane Library, and PubMed, from inception to 7 June 2020 to identify case-control studies that compared the oral and gut microbiome in adult RA patients with those of controls. The primary outcome was specific bacterial changes between RA and controls. The secondary outcome was microbial diversity changes between RA and controls.
In total, 26 articles were considered eligible for inclusion and reported some differences. Therein, ≥3 articles reported decreased Faecalibacterium in the gut of early-RA (ERA)/RA patients compared with healthy controls (HCs). Also, ≥3 articles reported decreased Streptococcus and Haemophilus and increased Prevotella in the oral cavity of ERA/RA patients compared with HCs. In addition, some Prevotella species, including P. histicola and P. oulorum, showed increased trends in RA patients' oral cavity, compared with HCs. The α-diversity of the microbiome was either increased or not changed in the oral cavity of RA patients, but it was more commonly either decreased or not changed in the gut of RA patients.
In this systematic review, we identified the microbiome associated with RA patients in comparison with controls. More research is needed in the future to find the deep relationship between RA and the microbiome.
最近,研究人员提出 RA 与口腔和肠道微生物组之间可能存在关系。然而,这种关系尚未得到系统的确立。在此,我们对相关文献进行了全面综述,以描述这种可能的关联。
我们系统地在数据库 EMBASE、Cochrane 图书馆和 PubMed 中进行了检索,检索时间从建库至 2020 年 6 月 7 日,以确定比较成人 RA 患者与对照组口腔和肠道微生物组的病例对照研究。主要结局是 RA 患者与对照组之间特定细菌的变化。次要结局是 RA 患者与对照组之间微生物多样性的变化。
共有 26 篇文章被认为符合纳入标准,并报告了一些差异。其中,≥3 篇文章报道了早期 RA(ERA)/RA 患者的肠道中粪杆菌减少,与健康对照组(HCs)相比。此外,≥3 篇文章报道了 ERA/RA 患者口腔中链球菌和嗜血杆菌减少,普雷沃氏菌增加,与 HCs 相比。此外,一些普雷沃氏菌属物种,包括 P. histicola 和 P. oulorum,在 RA 患者口腔中表现出增加的趋势,与 HCs 相比。RA 患者口腔微生物组的 α-多样性增加或不变,但 RA 患者肠道微生物组的 α-多样性更常见的是减少或不变。
在这项系统评价中,我们确定了与对照相比与 RA 患者相关的微生物组。未来需要更多的研究来发现 RA 与微生物组之间的深层关系。